Biologic Makers Thwart Generics: Winning Stocks

27-12-2013 YChartsComments (0)

GenericsTeva Pharmaceutical Industries

Almost four years after President Obama signed legislation creating a framework for FDA approval of less expensive, follow-on biologics, called biosimilars, manufacturers like Teva Pharmaceuticals (TEVA), Mylan (MYL), and Sandoz, the generic division ...

Read more on YCharts

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top